Amedeo Smart

Free Medical Literature Service

 

Amedeo

Inflammatory Bowel Diseases
  Free Subscription

Articles published in
Am J Gastroenterol
    October 2025
  1. KOCHAR B, Katz S, Faye AS
    Practical Advice for the Management of Older Adults With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025;120.
    >> Share

  2. HUAN PW, Mehta A, Wong ECL, Dulai PS, et al
    A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and Practice.
    Am J Gastroenterol. 2025;120:2242-2250.
    >> Share

  3. PARK Y MD, Park JH DDS, Leem GH, Song TJ MD, et al
    Periodontitis and the Incidence of Inflammatory Bowel Diseases: A Nationwide Population-Based Cohort Study.
    Am J Gastroenterol. 2025;120:2361-2372.
    >> Share

  4. SANDS BE, Rubin DT, Loftus EV Jr, Wolf DC, et al
    Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial.
    Am J Gastroenterol. 2025;120:2339-2349.
    >> Share

    September 2025
  5. RD L, Tc J, F Z, Y H, et al
    Gut microbiota are more strongly associated with impairments in health-related quality of life than disease activity in inflammatory bowel disease.
    Am J Gastroenterol. 2025 Sep 29. doi: 10.14309/ajg.0000000000003773.
    >> Share

  6. PAL P, Mateen MA, Pooja K, Marri UK, et al
    Correlation and assessment of small bowel lesions using cross sectional imaging techniques compared to small intestinal contrast ultrasonography in known Crohn's disease (the CACTUS-CD study): a paired, prospective, confirmatory study.
    Am J Gastroenterol. 2025 Sep 29. doi: 10.14309/ajg.0000000000003776.
    >> Share

  7. KURT G, Troelsen FS, Veres K, Sorensen HT, et al
    Risk of venous thromboembolism following colorectal cancer surgery in patients with and without inflammatory bowel disease.
    Am J Gastroenterol. 2025 Sep 3. doi: 10.14309/ajg.0000000000003761.
    >> Share

    August 2025
  8. ANDRE M, Kirchgesner J, Laharie D, Guillo L, et al
    Sub-cutaneous infliximab for perianal Crohn's disease: the BioLap-Rem multicentre study from the GETAID.
    Am J Gastroenterol. 2025 Aug 28. doi: 10.14309/ajg.0000000000003755.
    >> Share

  9. MAHADEVAN U, Seow CH, Barnes EL, Chaparro M, et al
    Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 Aug 27. doi: 10.14309/ajg.0000000000003651.
    >> Share

  10. YANOFSKY R, McDonald BD, Nikzad N, Choi D, et al
    New Eczematous Eruption in Patients with Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors.
    Am J Gastroenterol. 2025 Aug 22. doi: 10.14309/ajg.0000000000003742.
    >> Share

  11. ANTAYA M, Hudson AS, Lerner EP, Nasser K, et al
    The impact of integrating pelvic MRI at diagnosis on early detection of perianal Crohn's disease in pediatrics.
    Am J Gastroenterol. 2025 Aug 20. doi: 10.14309/ajg.0000000000003733.
    >> Share

  12. ZHANG Q, Liu H, Liu S, Zhu S, et al
    Increased mortality associated with sarcopenia in inflammatory bowel disease: a long-term prospective cohort study.
    Am J Gastroenterol. 2025 Aug 20. doi: 10.14309/ajg.0000000000003734.
    >> Share

  13. NARULA N, Wong ECL, Mente A, Rangarajan S, et al
    Ultra-Processed Grains and Risk of Inflammatory Bowel Disease: Results from the Prospective Urban Rural Epidemiology (PURE) Study.
    Am J Gastroenterol. 2025 Aug 4. doi: 10.14309/ajg.0000000000003700.
    >> Share

  14. BORRAS-BLASCO J, Valcuende-Rosique A, Cornejo-Uixeda S
    Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study).
    Am J Gastroenterol. 2025 Aug 4. doi: 10.14309/ajg.0000000000003619.
    >> Share

  15. KOCHAR B, Sun J, Olen O, Halfvarson J, et al
    Inflammatory bowel disease patients are at increased risk for interstitial lung diseases.
    Am J Gastroenterol. 2025 Aug 4. doi: 10.14309/ajg.0000000000003699.
    >> Share

    July 2025
  16. EBERT AC, Verstockt B, Bogsted M, Larsen L, et al
    Inflammatory bowel disease and risk of more than 1500 comorbidities: A disease-wide pre- and post-diagnostic phenomic association study.
    Am J Gastroenterol. 2025 Jul 30. doi: 10.14309/ajg.0000000000003673.
    >> Share

  17. DEZA DC, Dominguez CL, Oliver AP, Cuadro CP, et al
    The Patients Included in Clinical Trials of Biological Drugs for Inflammatory Bowel Disease Do Not Represent the Real-World Population.
    Am J Gastroenterol. 2025 Jul 30. doi: 10.14309/ajg.0000000000003670.
    >> Share

  18. NGUYEN NV, Sandstrom A, Dominicus A, Mageau A, et al
    Thiopurines and intrahepatic cholestasis of pregnancy in systemic lupus erythematosus and inflammatory bowel disease pregnancies.
    Am J Gastroenterol. 2025 Jul 23. doi: 10.14309/ajg.0000000000003652.
    >> Share

  19. ZHENG J, Huang P, Feng R, Li L, et al
    Early Improvement of Mental Health is Associated with Long-term Disease Remission in Ulcerative Colitis.
    Am J Gastroenterol. 2025 Jul 7. doi: 10.14309/ajg.0000000000003638.
    >> Share

  20. KOJIMA K, Takada J, Shimizu M
    Asymptomatic Yersinia Colitis Mimicking Neoplasia in Ulcerative Colitis.
    Am J Gastroenterol. 2025 Jul 2. doi: 10.14309/ajg.0000000000003626.
    >> Share

  21. FARRAYE FA, Melmed GY, Lichtenstein GR, Barnes EL, et al
    ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025;120:1447-1473.
    >> Share

    June 2025
  22. BARNES EL, Raffals L, Qazi T, Deepak P, et al
    A Prospective Comparison of Ustekinumab and Anti-TNF Therapy in the Treatment of Crohn's-like Disease of the Pouch.
    Am J Gastroenterol. 2025 Jun 25. doi: 10.14309/ajg.0000000000003608.
    >> Share

  23. MEYER A, Carbonnel F, Dahm CC, Halkjaer J, et al
    Fruits, vegetables, legumes and potatoes and risk of Crohn's disease and ulcerative colitis.
    Am J Gastroenterol. 2025 Jun 24. doi: 10.14309/ajg.0000000000003602.
    >> Share

  24. SALEH H, Horst S, Kinnucan J
    Dissatisfaction and Barriers in Electronic Health Record Use for Inflammatory Bowel Disease Patients: A Nationwide Survey of Major IBD Centers.
    Am J Gastroenterol. 2025 Jun 16. doi: 10.14309/ajg.0000000000003598.
    >> Share

  25. GAIDOS JKJ, Hashash JG
    Monitoring Inflammatory Bowel Disease Activity: When, How and Why.
    Am J Gastroenterol. 2025 Jun 9. doi: 10.14309/ajg.0000000000003582.
    >> Share

  26. SOLITANO V, Ogunsakin RE, Yuan Y, Bernstein CN, et al
    Effectiveness and Safety of Advanced Combination Treatment (ACT) in patients with refractory inflammatory bowel disease or concomitant immune mediated disease or extra-intestinal manifestations: A Multi-Center Canadian Study.
    Am J Gastroenterol. 2025 Jun 5. doi: 10.14309/ajg.0000000000003573.
    >> Share

  27. LICHTENSTEIN GR, Loftus EV, Afzali A, Long MD, et al
    ACG Clinical Guideline: Management of Crohn's Disease in Adults.
    Am J Gastroenterol. 2025;120:1225-1264.
    >> Share

  28. RUBIN DT, Ananthakrishnan AN, Siegel CA, Barnes EL, et al
    ACG Clinical Guideline Update: Ulcerative Colitis in Adults.
    Am J Gastroenterol. 2025;120:1187-1224.
    >> Share

    May 2025
  29. PAL P
    Listening Beyond the Symptoms: Existential Needs and Identity in Older Adults With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 May 27. doi: 10.14309/ajg.0000000000003514.
    >> Share

  30. DUGGAL S, Mahapatra S, Garrison K, Robles A, et al
    Assessing Gastrointestinal Awareness on TikTok: A Content Analysis of Colorectal Cancer, IBS, and IBD Narratives.
    Am J Gastroenterol. 2025 May 14. doi: 10.14309/ajg.0000000000003539.
    >> Share

  31. CHESTER MA, Keefer L
    Beyond Depression and Anxiety in Inflammatory Bowel Diseases: Forging a Path Toward Emotional Healing.
    Am J Gastroenterol. 2025;120:999-1006.
    >> Share

  32. ADLER J, Galanko JA, Ammoury R, Benkov KJ, et al
    HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.
    Am J Gastroenterol. 2025;120:1076-1086.
    >> Share

    April 2025
  33. KOCHHAR GS, Dziegielewski C, Schairer JN, Cross RK, et al
    Role of Endoscopy in Inflammatory Bowel Disease: What Every Gastroenterologist Should Know.
    Am J Gastroenterol. 2025 Apr 29. doi: 10.14309/ajg.0000000000003507.
    >> Share

  34. OHNO M, Nishida A, Yokota Y, Imai T, et al
    Early Stage Crohn's Disease-Associated Small Bowel Adenocarcinoma at Ileal Stenosis Detected by Ballon-Assisted Enteroscopy.
    Am J Gastroenterol. 2025 Apr 10. doi: 10.14309/ajg.0000000000003484.
    >> Share

  35. MELMED GY, Oliver B, Kennedy A, Hou JK, et al
    LONG-TERM SUSTAINED IMPROVEMENT IN UNPLANNED HEALTHCARE UTILIZATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
    Am J Gastroenterol. 2025 Apr 7. doi: 10.14309/ajg.0000000000003454.
    >> Share

  36. RUSHER A, Fuss A, Araka E, Cauley C, et al
    Existential Reflections by Older Adults With Inflammatory Bowel Diseases on Medical and Surgical Treatments.
    Am J Gastroenterol. 2025;120:1829-1838.
    >> Share

  37. SEGURA A, Brensinger C, Pate V, Siddique SM, et al
    Association of Race and Ethnicity with Healthcare Utilization for Inflammatory Bowel Disease in the United States: A Retrospective Cohort Study.
    Am J Gastroenterol. 2025 Apr 1. doi: 10.14309/ajg.0000000000003438.
    >> Share

  38. DRITTEL D, Schreiber-Stainthorp W, Delau O, Gurunathan SV, et al
    Severe Polypharmacy Increases Risk of Hospitalization Among Older Adults With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025;120:844-855.
    >> Share

    March 2025
  39. KAYAL M
    A Practical Guide to the Use of Guselkumab for Moderate-Severe Ulcerative Colitis.
    Am J Gastroenterol. 2025 Mar 31. doi: 10.14309/ajg.0000000000003446.
    >> Share

  40. DUNLEAVY K, Pedersen K, Cima R, Chedid V, et al
    Ileal pouch adenocarcinoma in a young patient with newly diagnosed Crohn's-like disease of the pouch.
    Am J Gastroenterol. 2025 Mar 26. doi: 10.14309/ajg.0000000000003426.
    >> Share

  41. CALDERA F, Hayney MS, Farraye FA, Fischer M, et al
    Low incidence of Varicella in Pediatric Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 Mar 18. doi: 10.14309/ajg.0000000000003418.
    >> Share

  42. TORRES J, Panes J, Siegel CA, Dubinsky MC, et al
    Symptom Resolution and Meaningful Improvement in Quality of Life With Risankizumab in Patients With Ulcerative Colitis: Post Hoc Analysis of the Randomized INSPIRE and COMMAND Studies.
    Am J Gastroenterol. 2025 Mar 17. doi: 10.14309/ajg.0000000000003420.
    >> Share

  43. LEE SD, Vermeire S, Ungaro R, Vadhariya A, et al
    Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 study.
    Am J Gastroenterol. 2025 Mar 13. doi: 10.14309/ajg.0000000000003410.
    >> Share

  44. LEE SD, Ehrlich AC, Pellanda P, Kaiser C, et al
    Long-Term Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis: An Integrated 2-Year Safety Analysis.
    Am J Gastroenterol. 2025 Mar 12. doi: 10.14309/ajg.0000000000003407.
    >> Share

  45. DZIEGIELEWSKI C, Yuan Y, Ma C, Boland BS, et al
    IL-23p19 Antagonists vs. Ustekinumab for Treatment of Crohn's Disease: A Meta-analysis of Randomized Controlled Trials.
    Am J Gastroenterol. 2025 Mar 12. doi: 10.14309/ajg.0000000000003406.
    >> Share

  46. YANG JC, Janssen EM, Wallace MJ, Sheahan A, et al
    Quantifying Patient Preferences for Risk Tolerance With Novel Dual Biologic Therapies for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 Mar 6. doi: 10.14309/ajg.0000000000003397.
    >> Share

  47. GOODWIN SW, Wilk P, Yuan Y, Haan M, et al
    Increasing rate of hospitalization for inflammatory bowel disease is an age-related effect: A Canadian Population Study.
    Am J Gastroenterol. 2025 Mar 4. doi: 10.14309/ajg.0000000000003385.
    >> Share

    February 2025
  48. LO B, Moller B, Igel C, Wildt S, et al
    Improving the Real-time Classification of Disease Severity in Ulcerative Colitis: Artificial Intelligence as the Trigger for a Second Opinion.
    Am J Gastroenterol. 2025 Feb 28. doi: 10.14309/ajg.0000000000003382.
    >> Share

  49. FU CJ, Chen HW, Wei JC
    Spine and Sacroiliac Joint Involvement in Newly Diagnosed Patients With Inflammatory Bowel Disease: Clinical and MRI Findings From a Population-Based Cohort.
    Am J Gastroenterol. 2025 Feb 25. doi: 10.14309/ajg.0000000000003340.
    >> Share

  50. NORGARD BM, Thorarinsson CT, Nielsen J, Dalal RS, et al
    Predictors for chronic opioid use in patients with inflammatory bowel disease - a population based cohort study.
    Am J Gastroenterol. 2025 Feb 5. doi: 10.14309/ajg.0000000000003353.
    >> Share

  51. CALAFAT M, Suria C, Mesonero F, de Francisco R, et al
    HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA Registry.
    Am J Gastroenterol. 2025;120:431-439.
    >> Share

  52. SYSTROM HK, Rai V, Singh S, Baidoo L, et al
    When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025;120:420-430.
    >> Share

    January 2025
  53. STEINSBO O, Aasprong OG, Aabakken L, Karlsen LN, et al
    Fecal Calprotectin Correlates with Disease Extent but Remains a Reliable Marker of Mucosal Healing in Ulcerative Colitis.
    Am J Gastroenterol. 2025 Jan 30. doi: 10.14309/ajg.0000000000003339.
    >> Share

  54. OLIVERA PA, Parks ML, Zubiaurre I, Peyrin-Biroulet L, et al
    Comparative Improvement in Health-Related Quality of Life with Advanced Therapies for Moderate-to-Severe Crohn's Disease: A Network Meta-Analysis.
    Am J Gastroenterol. 2025 Jan 29. doi: 10.14309/ajg.0000000000003333.
    >> Share

  55. MARILD K, Soderling J, Stephansson O, Axelrad J, et al
    Inflammatory Bowel Disease, Periconceptional Disease Activity, and Risk of Major Congenital Anomalies: A Nationwide Cohort Study.
    Am J Gastroenterol. 2025 Jan 8. doi: 10.14309/ajg.0000000000003306.
    >> Share

  56. MEMEL Z, Yu A, Fenton C, Wen T, et al
    The Effect of Low-dose Aspirin on Disease Activity in Pregnant Individuals with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 Jan 7. doi: 10.14309/ajg.0000000000003304.
    >> Share

  57. HONG SJ, Dalal RS, Kuhn KA, Stahly A, et al
    Prevalence and Risk Factors of Spondyloarthritis Symptoms in a US-Based Multicenter Cohort of Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025 Jan 6. doi: 10.14309/ajg.0000000000003292.
    >> Share

  58. GIORDANO A, Perez-Martinez I, Gisbert JP, Ricart E, et al
    Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.
    Am J Gastroenterol. 2025;120:194-203.
    >> Share

  59. SYAL G, Barnes E, Raffals L, Al Kazzi E, et al
    Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders-A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2025;120:135-150.
    >> Share

    December 2024
  60. ALLEGRETTI JR, Cheifetz AS, Dulai PS, Stevens AC, et al
    SAFETY, PHARMACOKINETICS, AND CLINICAL EFFICACY OF ADS051, A NEUTROPHIL MODULATOR, IN ULCERATIVE COLITIS: RESULTS OF A RANDOMIZED PHASE 1B TRIAL.
    Am J Gastroenterol. 2024 Dec 31. doi: 10.14309/ajg.0000000000003269.
    >> Share

  61. TANDON P, Huang V, Feig DS, Saskin R, et al
    Health-Care Utilization of Children Born to Women with and Without Inflammatory Bowel Disease in the First Five Years of Life: A Population-Cohort Study.
    Am J Gastroenterol. 2024 Dec 31. doi: 10.14309/ajg.0000000000003280.
    >> Share

  62. CHETWOOD JD, Paramsothy S, Leong RW
    Infliximab and adalimumab in the treatment of fistulizing Crohn's disease: a propensity score-matched analysis from the prospective Persistence Australian National IBD Cohort (PANIC4) study.
    Am J Gastroenterol. 2024 Dec 30. doi: 10.14309/ajg.0000000000003271.
    >> Share

  63. RODRIGUEZ-LAGO I, Aguirre U, Cabriada JL, Ungaro RC, et al
    Increased medication utilization precedes incidentally diagnosed inflammatory bowel disease: a multicenter, case-control study.
    Am J Gastroenterol. 2024 Dec 30. doi: 10.14309/ajg.0000000000003275.
    >> Share

  64. GAO Z, Qi J, Ye W
    Comment on "Gallstone Disease Is Associated With an Increased Risk of Inflammatory Bowel Disease: Results From 3 Prospective Cohort Studies".
    Am J Gastroenterol. 2024 Dec 10. doi: 10.14309/ajg.0000000000003186.
    >> Share

    November 2024
  65. GARCIA MJ, Brenes Y, Vicuna M, Bermejo F, et al
    PERSISTENCE, EFFECTIVENESS, AND SAFETY OF UPADACITINIB IN CROHN'S DISEASE AND ULCERATIVE COLITIS IN REAL LIFE: RESULTS FROM A SPANISH NATIONWIDE STUDY (UREAL STUDY): Upadacitinib for IBD.
    Am J Gastroenterol. 2024 Nov 26. doi: 10.14309/ajg.0000000000003243.
    >> Share

  66. CHEIFETZ AS, Allegretti JR, Quintas M, Dixit B, et al
    Small-Molecule Neutrophil Modulator ADS051 is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose Study.
    Am J Gastroenterol. 2024;120:1585-1592.
    >> Share

  67. SOLITANO V, Narula N, Ma C, Nanayakkara A, et al
    Effectiveness of Ustekinumab for patients with moderate to severe Ulcerative Colitis: A Multi-Center Real-World Canadian Study.
    Am J Gastroenterol. 2024 Nov 14. doi: 10.14309/ajg.0000000000003212.
    >> Share

  68. ANDERSON SR, Ayoub M, Coats S, McHenry S, et al
    Safety and Effectiveness of Glucagon-like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2024 Nov 14. doi: 10.14309/ajg.0000000000003208.
    >> Share

  69. TANG WZ, Li JZ, Liu TH
    Tofacitinib vs Biologics: Postoperative Concerns in Ulcerative Colitis Colectomies.
    Am J Gastroenterol. 2024 Nov 14. doi: 10.14309/ajg.0000000000003148.
    >> Share

  70. KAO D, Wong K, Jijon H, Moayyedi P, et al
    Preliminary results from a multicenter, randomized trial using fecal microbial transplantation to induce remission in patients with mild to moderate Crohn's disease.
    Am J Gastroenterol. 2024 Nov 12. doi: 10.14309/ajg.0000000000003196.
    >> Share

    October 2024
  71. ISAACS KL, Sayed CJ
    Nonmalignant dermatologic disorders in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2024 Oct 23. doi: 10.14309/ajg.0000000000003155.
    >> Share

  72. DANPANICHKUL P, Duangsonk K, Ho AH, Laoveeravat P, et al
    Disproportionately Increasing Incidence of Inflammatory Bowel Disease in Females and the Elderly: An Update Analysis from the Global Burden of Disease Study 2021.
    Am J Gastroenterol. 2024 Oct 18. doi: 10.14309/ajg.0000000000003143.
    >> Share

  73. ADLER J, Galanko JA, Ammoury R, Benkov KJ, et al
    HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's Disease.
    Am J Gastroenterol. 2024 Oct 18. doi: 10.14309/ajg.0000000000003135.
    >> Share

  74. KHAN N, Patel D, Sundararajan R
    Incidence of thiopurine induced severe myelosuppression in a nationwide cohort of inflammatory bowel disease patients.
    Am J Gastroenterol. 2024 Oct 18. doi: 10.14309/ajg.0000000000003141.
    >> Share

  75. CHEN J, Zhai C, Pan H
    Focusing on the Key Factors in the Treatment of Pediatric Crohn's Disease: A Re-Examination of the Relationship Between Body Mass Index and Antitumor Necrosis Factor Treatment Response.
    Am J Gastroenterol. 2024 Oct 10. doi: 10.14309/ajg.0000000000003101.
    >> Share

  76. TEMIDO MJ, Honap S, Bursztejn AC, Portela F, et al
    Drug-Induced Acne in Inflammatory Bowel Disease: A Practical Guide for the Gastroenterologist.
    Am J Gastroenterol. 2024 Oct 9. doi: 10.14309/ajg.0000000000003119.
    >> Share

  77. MI N, Yang M, Wei L, Nie P, et al
    Gallstone disease is associated with an increased risk of inflammatory bowel disease: results from three prospective cohort studies.
    Am J Gastroenterol. 2024 Oct 4. doi: 10.14309/ajg.0000000000003111.
    >> Share

  78. ABREU MT, Kosinski LR
    Correction to: How Did It Get So Difficult to Care for Patients With Inflammatory Bowel Disease?
    Am J Gastroenterol. 2024 Oct 3. doi: 10.14309/ajg.0000000000003051.
    >> Share

    September 2024
  79. LIN CP, Kuo P, Wei JC
    Addressing Additional Limitations in the Study on Small Intestine Cancer Risk in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2024 Sep 27. doi: 10.14309/ajg.0000000000003053.
    >> Share

  80. CHO Y, Choi EY, Choi A, Han JY, et al
    Anti-Tumor Necrosis Factor Therapy and the Risk of Gestational Diabetes in Pregnant Women with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2024 Sep 24. doi: 10.14309/ajg.0000000000003100.
    >> Share

  81. FALLOON K, Forney M, Husni ME, Feagan B, et al
    Diagnosis and Management of Inflammatory Bowel Disease Associated Spondyloarthritis.
    Am J Gastroenterol. 2024 Sep 23. doi: 10.14309/ajg.0000000000003092.
    >> Share

  82. ISSOKSON K, Lee DY, Yarur AJ, Lewis JD, et al
    The Role of Diet in Inflammatory Bowel Disease Onset, Disease Management, and Surgical Optimization.
    Am J Gastroenterol. 2024 Sep 19. doi: 10.14309/ajg.0000000000003085.
    >> Share

  83. VAUGHN BP, Khoruts A, Fischer M
    Diagnosis and management of Clostridioides difficile in inflammatory bowel disease.
    Am J Gastroenterol. 2024 Sep 4. doi: 10.14309/ajg.0000000000003076.
    >> Share

  84. YANG JY, Lund JL, Funk MJ, Hudgens MG, et al
    Correction to: Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2024;119:1950.
    >> Share

    August 2024
  85. KAYAL M, Posner H, Jimenez D, Huang J, et al
    Endoscopic Response Reduces the Risk of Subsequent Pouchitis in Patients with Crohn's Disease Like Pouch Inflammation.
    Am J Gastroenterol. 2024 Aug 27. doi: 10.14309/ajg.0000000000003055.
    >> Share

  86. VLADIMIROVA N, Moller J, Attauabi M, Madsen G, et al
    Spine and sacroiliac joint involvement in newly diagnosed inflammatory bowel disease patients - clinical and magnetic resonance imaging findings from a population-based cohort.
    Am J Gastroenterol. 2024 Aug 20. doi: 10.14309/ajg.0000000000003039.
    >> Share

  87. NAUDE C, Skvarc D, Maunick B, Evans S, et al
    Acceptance & Commitment Therapy for Adults Living With Inflammatory Bowel Disease & Distress: A Randomized Controlled Trial.
    Am J Gastroenterol. 2024 Aug 20. doi: 10.14309/ajg.0000000000003032.
    >> Share

  88. DAI C, Huang YH, Jiang M
    Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis Factors in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2024 Aug 19. doi: 10.14309/ajg.0000000000002995.
    >> Share

  89. AHMED NS, Krawchuk S, Buhler KA, Solitano V, et al
    US National Estimates of Contemporary Mortality Rates in Patients with Ulcerative Colitis Undergoing Colectomy.
    Am J Gastroenterol. 2024 Aug 14. doi: 10.14309/ajg.0000000000003031.
    >> Share

    July 2024
  90. GLEAVE A, Shah A, Tahir U, Blom JJ, et al
    Using Diet to Treat Inflammatory Bowel Disease: A Systematic Review.
    Am J Gastroenterol. 2024 Jul 26. doi: 10.14309/ajg.0000000000002973.
    >> Share

  91. LEE JW, Woo D, Kim KO, Kim ES, et al
    Deep learning model using stool pictures for predicting endoscopic mucosal inflammation in patients with ulcerative colitis.
    Am J Gastroenterol. 2024 Jul 25. doi: 10.14309/ajg.0000000000002978.
    >> Share

  92. ALSAKARNEH S, Ahmed M, Azim S, Hashash JG, et al
    Risk of Small Intestine Cancer in Inflammatory Bowel Disease: A Propensity-Matched Study from a Large Multi-Center Database in the United States.
    Am J Gastroenterol. 2024 Jul 25. doi: 10.14309/ajg.0000000000002984.
    >> Share

  93. PINNUCK B, Lynch KD
    Mortality in Acute Severe Ulcerative Colitis - Still an Alarming and Real Complication in the Era of Advanced Therapies.
    Am J Gastroenterol. 2024 Jul 16. doi: 10.14309/ajg.0000000000002917.
    >> Share

  94. CALAFAT M, Suria C, Mesonero F, de Francisco R, et al
    HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study of the ENEIDA registry.
    Am J Gastroenterol. 2024 Jul 15. doi: 10.14309/ajg.0000000000002965.
    >> Share

  95. SHAH RS, Hu JH, Bachour S, Joseph A, et al
    Histologic Activity from Neoterminal Ileal Biopsies in Patients with Crohn's Disease in Endoscopic Remission is Associated with Postoperative Recurrence.
    Am J Gastroenterol. 2024 Jul 15. doi: 10.14309/ajg.0000000000002963.
    >> Share

  96. KARLQVIST S, Sachs MC, Eriksson C, Cao Y, et al
    Comparative risk of serious infection with vedolizumab vs anti-TNF in inflammatory bowel disease: results from nationwide Swedish registers.
    Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002961.
    >> Share

  97. KOCHHAR GS, Khataniar H, Jairath V, Farraye FA, et al
    Comparative Effectiveness of Upadacitinib and Tofacitinib in Ulcerative Colitis: A U.S. Propensity-Matched Cohort Study.
    Am J Gastroenterol. 2024 Jul 5. doi: 10.14309/ajg.0000000000002947.
    >> Share

  98. DEJONG N, Zhang X, Kappelman M
    Prevalence of Preceding and Follow-up Outpatient Care Surrounding Emergency Department Visits for Pediatric Inflammatory Bowel Disease: Identifying Opportunities for Quality Improvement.
    Am J Gastroenterol. 2024 Jul 5. doi: 10.14309/ajg.0000000000002936.
    >> Share

  99. TANDON P, Huang V, Feig DS, Saskin R, et al
    Recent Immigrants With Inflammatory Bowel Disease Have Significant Healthcare Utilization From Preconception to Postpartum: A Population Cohort Study.
    Am J Gastroenterol. 2024;119:1346-1354.
    >> Share

    June 2024
  100. MURTHY SK, Tandon P, Matthews P, Ahmed F, et al
    A Population-Based Matched Cohort Study of Digestive System Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease.
    Am J Gastroenterol. 2024 Jun 25. doi: 10.14309/ajg.0000000000002900.
    >> Share

  101. BARNES EL, Desai A, Hashash JG, Farraye FA, et al
    The Natural History after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Population-Based Cohort Study from the United States.
    Am J Gastroenterol. 2024 Jun 18. doi: 10.14309/ajg.0000000000002891.
    >> Share

  102. KATHURIA P, Higgins PDR, Berinstein JA
    Timing Is Everything: The Lifesaving Potential of Early Medical Therapy in Acute Severe Ulcerative Colitis.
    Am J Gastroenterol. 2024 Jun 12. doi: 10.14309/ajg.0000000000002867.
    >> Share

  103. CONSTANT BD, Long MD, Scott FI, Higgins PDR, et al
    Associated With Decreased Insurance Satisfaction and Adverse Clinical Outcomes: An Inflammatory Bowel Disease Partners Survey.
    Am J Gastroenterol. 2024 Jun 3. doi: 10.14309/ajg.0000000000002851.
    >> Share

    May 2024
  104. NOURELDIN M, Van T, Cohen-Mekelburg S, Scott FI, et al
    Legalization of Cannabis Does Not Reduce Opioid Prescribing in Patients With Inflammatory Bowel Disease: A Difference-in-Difference Analysis.
    Am J Gastroenterol. 2024 May 21. doi: 10.14309/ajg.0000000000002834.
    >> Share

  105. KARIME C, Black CN, Cortes P, Kwon JY, et al
    Utility of a Third Heplisav-B Dose in Patients with Inflammatory Bowel Disease without Immunity Following Two-Dose Heplisav-B Vaccination.
    Am J Gastroenterol. 2024 May 8. doi: 10.14309/ajg.0000000000002863.
    >> Share

  106. NARULA N, Hamam H, Peerani F, Bessissow T, et al
    Resolution of rectal bleeding by day 7 in acute severe ulcerative colitis is prognostic for post-discharge corticosteroid free clinical remission and endoscopic improvement.
    Am J Gastroenterol. 2024 May 8. doi: 10.14309/ajg.0000000000002860.
    >> Share

  107. WU S, Liu Y, He Z, Bai Y, et al
    The Association Between Ultra-Processed Foods and Inflammatory Bowel Disease: Far More Complex Than Thought.
    Am J Gastroenterol. 2024 May 3. doi: 10.14309/ajg.0000000000002815.
    >> Share

  108. BERNSTEIN CN, Fisk JD, Dolovich C, Hitchon CA, et al
    Understanding Predictors of Fatigue Over Time in Persons With Inflammatory Bowel Disease: The Importance of Depressive and Anxiety Symptoms.
    Am J Gastroenterol. 2024;119:922-929.
    >> Share

    April 2024
  109. ABREU MT, Kosinski LR
    How Did It Get So Difficult to Care for Patients With Inflammatory Bowel Disease?
    Am J Gastroenterol. 2024 Apr 30. doi: 10.14309/ajg.0000000000002794.
    >> Share

  110. STIDHAM RW, Enchakalody B, Wang SC, Su GL, et al
    Artificial Intelligence for Quantifying Cumulative Small Bowel Disease Severity on CT-Enterography in Crohn's Disease.
    Am J Gastroenterol. 2024 Apr 25. doi: 10.14309/ajg.0000000000002828.
    >> Share

  111. MOHAMED MFH, Marino D, Elfert K, Beran A, et al
    Dye Chromoendoscopy Outperforms High-Definition White Light Endoscopy in Dysplasia Detection for Patients With Inflammatory Bowel Disease: An Updated Meta-Analysis of Randomized Controlled Trials.
    Am J Gastroenterol. 2024;119:719-726.
    >> Share

    March 2024
  112. ALLEGRETTI JR, Axelrad J, Dalal RS, Kelly CR, et al
    Outcomes after Fecal Microbiota Transplantation in combination with Bezlotoxumab for Inflammatory Bowel Disease and Recurrent C . difficile Infection.
    Am J Gastroenterol. 2024 Mar 19. doi: 10.14309/ajg.0000000000002770.
    >> Share

  113. KHAN N, Sundararajan R, Patel M, Trivedi C, et al
    Effectiveness Of Tofacitinib In Ulcerative Colitis Patients: A Nationwide Veterans Administration Cohort study.
    Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002761.
    >> Share

  114. DALAL RS, Kallumkal G, Cabral HJ, Barnes EL, et al
    One-Year Comparative Effectiveness of Upadacitinib Versus Tofacitinib For Ulcerative Colitis: A Multicenter Cohort Study.
    Am J Gastroenterol. 2024 Mar 12. doi: 10.14309/ajg.0000000000002746.
    >> Share

  115. EBACH DR, Jester TW, Galanko JA, Firestine AM, et al
    High Body Mass Index and Response to Anti-TNF Therapy in Pediatric Crohn Disease.
    Am J Gastroenterol. 2024 Mar 6. doi: 10.14309/ajg.0000000000002741.
    >> Share

  116. CHUGH R, Long MD, Jiang Y, Weaver KN, et al
    Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results From the PIANO Registry.
    Am J Gastroenterol. 2024;119:468-476.
    >> Share

    February 2024
  117. ANDERSON KL, Anand R, Feuerstein JD
    Insurance Companies' Poor Adherence to Guidelines for Moderate to Severe Ulcerative Colitis/Crohn's Disease Management.
    Am J Gastroenterol. 2024 Feb 29. doi: 10.14309/ajg.0000000000002720.
    >> Share

  118. FRIEDMAN S, Nielsen J, Qvist N, Knudsen T, et al
    Does surgery prior to pregnancy in women with inflammatory bowel disease increase the risk of adverse maternal and fetal outcomes? A Danish national cohort study.
    Am J Gastroenterol. 2024 Feb 20. doi: 10.14309/ajg.0000000000002732.
    >> Share

  119. HERFARTH H
    Dysplasia Detection in Inflammatory Bowel Disease: An Updated Meta-Analysis With Effect.
    Am J Gastroenterol. 2024 Feb 16. doi: 10.14309/ajg.0000000000002658.
    >> Share

  120. SMITH RA, Desai A, Barnes EL, Hayney M, et al
    Patients with Inflammatory Bowel Disease are at Increased Risk for Hospitalization Due to Respiratory Syncytial Virus.
    Am J Gastroenterol. 2024 Feb 6. doi: 10.14309/ajg.0000000000002682.
    >> Share

  121. SUN J, Yao J, Olen O, Halfvarson J, et al
    Long-term risk of myocarditis in patients with inflammatory bowel disease: a nationwide cohort study in Sweden.
    Am J Gastroenterol. 2024 Feb 5. doi: 10.14309/ajg.0000000000002701.
    >> Share

  122. COHEN-MEKELBURG S, Valicevic A, Lin L, Saini SD, et al
    Inflammatory Bowel Disease Hospitalizations are Similar for Patients Receiving Tele-Visit Delivered Outpatient Care and Those Receiving Traditional In-Person Care.
    Am J Gastroenterol. 2024 Feb 5. doi: 10.14309/ajg.0000000000002703.
    >> Share

  123. VAGIANOS K, Dolovich C, Witges K, Graff LA, et al
    Ultra-processed food, disease activity and inflammation in Ulcerative Colitis: The Manitoba Living with IBD Study.
    Am J Gastroenterol. 2024 Feb 2. doi: 10.14309/ajg.0000000000002667.
    >> Share

  124. DRAGONI G, Innocenti T, Amiot A, Castiglione F, et al
    Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study.
    Am J Gastroenterol. 2024 Feb 2. doi: 10.14309/ajg.0000000000002676.
    >> Share

  125. ANDREW B, Trinh S, Zhou A, Vasudevan A, et al
    Anal Cancer in Crohn's Disease: The Need to Optimize Treatment and Improve Surveillance.
    Am J Gastroenterol. 2024;119:390-391.
    >> Share

  126. COWARD S, Benchimol EI, Bernstein CN, Avina-Zubieta A, et al
    Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian nationwide analysis.
    Am J Gastroenterol. 2024 Feb 1. doi: 10.14309/ajg.0000000000002687.
    >> Share

  127. FAYE AS, Axelrad JE, Sun J, Halfvarson J, et al
    Atherosclerosis as a Risk Factor of Inflammatory Bowel Disease: A Population-Based Case-Control Study.
    Am J Gastroenterol. 2024;119:313-322.
    >> Share

  128. DALAL RS, Norgard BM, Zegers FD, Kjeldsen J, et al
    Older Adult-Onset of Inflammatory Bowel Diseases Is Associated With Higher Utilization of Analgesics: A Nationwide Cohort Study.
    Am J Gastroenterol. 2024;119:323-330.
    >> Share

  129. FEAGINS LA, Gold S, Steinlauf AF
    Overview of Biosimilars in Inflammatory Bowel Diseases.
    Am J Gastroenterol. 2024;119:229-232.
    >> Share

    January 2024
  130. CHETWOOD JD, Ko Y, Pudipeddi A, Kariyawasam V, et al
    Biological agents in the treatment of Crohn's disease: a propensity score-matched analysis from the prospective Persistence Australian National IBD Cohort (PANIC3) study.
    Am J Gastroenterol. 2024 Jan 26. doi: 10.14309/ajg.0000000000002679.
    >> Share

  131. BERINSTEIN JA, Karl T, Patel A, Dolinger M, et al
    Effectiveness of Upadacitinib for Patients with Acute Severe Ulcerative Colitis: A Multi-Center Experience.
    Am J Gastroenterol. 2024 Jan 26. doi: 10.14309/ajg.0000000000002674.
    >> Share

  132. TANDON P, Huang V, Feig DS, Saskin R, et al
    Recent Immigrants with Inflammatory Bowel Disease Have Significant Health-Care Utilization from Preconception to Postpartum: A Population Cohort Study.
    Am J Gastroenterol. 2024 Jan 23. doi: 10.14309/ajg.0000000000002668.
    >> Share

  133. NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
    Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naive Crohn's Disease.
    Am J Gastroenterol. 2024 Jan 18. doi: 10.14309/ajg.0000000000002654.
    >> Share

  134. MA T, Han D, Sun M
    Acute Pancreatitis After Microscopic Colitis: Is It due to Drugs or Disease?
    Am J Gastroenterol. 2024;119:215-216.
    >> Share

  135. KIWAN W
    Continuing Medical Education Questions: January 2024.
    Am J Gastroenterol. 2024;119:29.
    >> Share

    December 2023
  136. DOLINGER MT, Aronskyy I, Kellar A, Gao M, et al
    Determining the accuracy of intestinal ultrasound scores as a pre-screening tool in Crohn's disease clinical trials.
    Am J Gastroenterol. 2023 Dec 22. doi: 10.14309/ajg.0000000000002632.
    >> Share

  137. SINGH A, Goyal MK, Midha V, Mahajan R, et al
    Tofacitinib in acute severe ulcerative colitis (TACOS): A randomized controlled trial: Tofacitinib in ASUC.
    Am J Gastroenterol. 2023 Dec 22. doi: 10.14309/ajg.0000000000002635.
    >> Share

  138. AFIF W, Arasaradnam RP, Abreu MT, Danese S, et al
    Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-term Maintenance Study.
    Am J Gastroenterol. 2023 Dec 14. doi: 10.14309/ajg.0000000000002621.
    >> Share

  139. WEI L, Patil SA, Cross RK, Taubenslag KJ, et al
    Cystoid macular edema after initiation of ozanimod for ulcerative colitis.
    Am J Gastroenterol. 2023 Dec 12. doi: 10.14309/ajg.0000000000002622.
    >> Share

  140. BOUSVAROS A
    Collaborative Registries for Pediatric Crohn's Disease: A Leap Forward or More of the Same?
    Am J Gastroenterol. 2023 Dec 5. doi: 10.14309/ajg.0000000000002590.
    >> Share

  141. WEISS A, Barnes EL, Bewtra M
    A Practical Guide to the Use of Upadacitinib in Ulcerative Colitis and Crohn's Disease.
    Am J Gastroenterol. 2023 Dec 4. doi: 10.14309/ajg.0000000000002598.
    >> Share

  142. BOURGONJE AR, Mian P
    Identifying Phenotypic Determinants of Infliximab Target Concentrations in Inflammatory Bowel Disease: Toward Personalized Evidence-Based Dosing Regimens.
    Am J Gastroenterol. 2023;118:2308-2309.
    >> Share

  143. DULANEY DT
    Continuing Medical Education Questions: December 2023.
    Am J Gastroenterol. 2023;118:2122.
    >> Share

    November 2023
  144. KAYAL M, Deepak P, Beniwal-Patel P, Raffals L, et al
    Changes in Therapy Are Not Associated with Increased Remission in Patients with Crohn's Disease of the Pouch.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002599.
    >> Share

  145. ANDREW B, Vasudevan A, Srinivasan A
    The Role of Intestinal Ultrasound During Pregnancy in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2023;118:2096-2097.
    >> Share

  146. BARNES EL, Desai A, Kochhar GS
    The Comparative Effectiveness of Ciprofloxacin and Metronidazole for an Initial Episode of Pouchitis: A Propensity-Matched Study.
    Am J Gastroenterol. 2023;118:1989-1996.
    >> Share

  147. SANTIAGO P, Barnes EL, Raffals LE
    Classification and Management of Disorders of the J Pouch.
    Am J Gastroenterol. 2023;118:1931-1939.
    >> Share

  148. SACHDEVA K, Agarwal S, Kumar P, Mathew D, et al
    Revised Algorithmic Approach to Differentiate Between Nonspecific and Specific Etiologies of Chronic Terminal Ileitis.
    Am J Gastroenterol. 2023;118:2052-2060.
    >> Share

  149. YARUR AJ, Abreu MT, Deepak P, Beniwal-Patel P, et al
    Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
    Am J Gastroenterol. 2023;118:2005-2013.
    >> Share

  150. MOHAN BP, Fatima N, Khan SR, Kassab L, et al
    Early Remission With Induction Therapy Predicts Long-Term Remission in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2023;118:2084-2087.
    >> Share

  151. KOCHAR B, Mao EJ, Shah SA
    Optimal Dysplasia Detection and Management in IBD: Now and in the Future.
    Am J Gastroenterol. 2023;118:1905-1908.
    >> Share

  152. DUNLEAVY KA, Cross RK, Raffals LE
    Causes, Diagnostic Testing, and Treatment of Residual Symptoms in Patients With IBD With Quiescent Disease.
    Am J Gastroenterol. 2023;118:1909-1914.
    >> Share

    October 2023
  153. GENERE JR, Ballard DH, Deepak P
    Three-Dimensional Modeling to Guide Interventional Endoscopy in Fibrostenotic Crohn's Disease.
    Am J Gastroenterol. 2023 Oct 13. doi: 10.14309/ajg.0000000000002558.
    >> Share

  154. PHAM JT, Ghusn W, Acosta A, Loftus EV Jr, et al
    Effectiveness and Safety of Antiobesity Medications in Patients With Obesity and Inflammatory Bowel Disease.
    Am J Gastroenterol. 2023 Oct 9. doi: 10.14309/ajg.0000000000002490.
    >> Share

  155. DEBRUYN JC, Huynh HQ, Griffiths AM, Jacobson K, et al
    ADALIMUMAB VERSUS INFLIXIMAB IN LUMINAL PEDIATRIC CROHN'S DISEASE: COMPARABLE OUTCOMES IN A PROSPECTIVE MULTICENTER COHORT STUDY.
    Am J Gastroenterol. 2023 Oct 3. doi: 10.14309/ajg.0000000000002552.
    >> Share

  156. SHUJA A
    Continuing Medical Education Questions: October 2023.
    Am J Gastroenterol. 2023;118:1742.
    >> Share

  157. COELHO-PRABHU N, Lewis JD
    Update on Endoscopic Dysplasia Surveillance in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2023;118:1748-1755.
    >> Share

    September 2023
  158. ALSOUD D, Ho J, Sabino J, Ferrante M, et al
    Utility of the Serum-Based Endoscopic Healing Index in Monitoring Therapeutic Response in Ulcerative Colitis.
    Am J Gastroenterol. 2023 Sep 27. doi: 10.14309/ajg.0000000000002518.
    >> Share

  159. BAK MTJ, Huinink STB, Erler NS, Bodelier AGL, et al
    Prognostic value of the modified Rutgeerts' score for long-term outcomes after primary ileocecal resection in Crohn's disease.
    Am J Gastroenterol. 2023 Sep 22. doi: 10.14309/ajg.0000000000002509.
    >> Share

  160. CAIRNS CA, Cross RK, Khambaty M, Bafford AC, et al
    Monitoring Patients with Inflammatory Bowel Disease at High Risk of Anal Cancer.
    Am J Gastroenterol. 2023 Sep 18. doi: 10.14309/ajg.0000000000002503.
    >> Share

  161. SANTIAGO P, Coelho-Prabhu N, Lennon R, Rui S, et al
    Baseline Clinical Factors are Associated with Risk of Complications in Crohn's Disease: Appraisal of the AGA Clinical Care Pathway.
    Am J Gastroenterol. 2023 Sep 15. doi: 10.14309/ajg.0000000000002498.
    >> Share

  162. WILKERSON RC
    Continuing Medical Education Questions: September 2023.
    Am J Gastroenterol. 2023;118:1543.
    >> Share

  163. KAHN-BOESEL O, Cautha S, Ufere NN, Ananthakrishnan AN, et al
    A Narrative Review of Financial Burden, Distress, and Toxicity of Inflammatory Bowel Diseases in the United States.
    Am J Gastroenterol. 2023;118:1545-1553.
    >> Share

    August 2023
  164. CHANG S, Murphy M, Malter L
    A Review of Available Medical Therapies to Treat Moderate to Severe Inflammatory Bowel Disease in 2023.
    Am J Gastroenterol. 2023 Aug 24. doi: 10.14309/ajg.0000000000002485.
    >> Share

  165. LEVARTOVSKY A, Ben-Horin S, Kopylov U, Klang E, et al
    Towards AI-Augmented Clinical Decision Making: An Examination of ChatGPT's Utility in Acute Ulcerative Colitis Presentations.
    Am J Gastroenterol. 2023 Aug 23. doi: 10.14309/ajg.0000000000002483.
    >> Share

  166. YANG Y, Ludvigsson JF, Olen O, Sjolander A, et al
    Absolute and relative risks of kidney and urological complications in patients with inflammatory bowel disease.
    Am J Gastroenterol. 2023 Aug 10. doi: 10.14309/ajg.0000000000002473.
    >> Share

  167. RAMPERTAB SD
    Continuing Medical Education Questions: August 2023.
    Am J Gastroenterol. 2023;118:1321.
    >> Share

  168. BOPARAI ES, Lee JK, Zhu S, Shirazi A, et al
    The Contemporary Probability of Occult Colorectal Cancer in Patients With Colitis-Related Dysplasia Undergoing Colectomy.
    Am J Gastroenterol. 2023;118:1453-1456.
    >> Share

    July 2023
  169. DUBINSKY M, Bleakman AP, Panaccione R, Hibi T, et al
    Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions.
    Am J Gastroenterol. 2023 Jul 12. doi: 10.14309/ajg.0000000000002404.
    >> Share

  170. FERNANDEZ C, Gajic Z, Esen E, Remzi F, et al
    Preoperative Risk Factors for Adverse Events in Adults Undergoing Bowel Resection for Inflammatory Bowel Disease: 15-Year Assessment of ACS-NSQIP.
    Am J Gastroenterol. 2023 Jul 7. doi: 10.14309/ajg.0000000000002395.
    >> Share

  171. BONFILS L, Sandri AK, Poulsen GJ, Agrawal M, et al
    Medication-wide study: Exploring medication use ten years prior to a diagnosis of inflammatory bowel disease.
    Am J Gastroenterol. 2023 Jul 7. doi: 10.14309/ajg.0000000000002399.
    >> Share

  172. BACHOUR SP, Khan MZ, Shah RS, Joseph A, et al
    Anastomotic configuration and temporary diverting ileostomy do not increase risk for anastomotic stricture in postoperative Crohn's disease.
    Am J Gastroenterol. 2023 Jul 7. doi: 10.14309/ajg.0000000000002393.
    >> Share

  173. VUYYURU SK, Archer M, Nguyen TM, Beaton M, et al
    Long washout periods between biologics for inflammatory bowel disease clinical trials are unnecessary: A Canadian retrospective cohort study.
    Am J Gastroenterol. 2023 Jul 6. doi: 10.14309/ajg.0000000000002398.
    >> Share

  174. BALI AS, Hashash JG, Picco MF, Kinnucan JA, et al
    Electronic Health Record Burden Among Gastroenterology Providers Associated With Subspecialty and Training.
    Am J Gastroenterol. 2023;118:1282-1284.
    >> Share

    June 2023
  175. HU FH, Chen HL
    Low Risk of Lymphoma in Pediatric Patients Treated for Inflammatory Bowel Disease: Need More Evidence.
    Am J Gastroenterol. 2023;118:1101-1102.
    >> Share

  176. DULANEY DT
    Continuing Medical Education Questions: June 2023.
    Am J Gastroenterol. 2023;118:935.
    >> Share

  177. DULANEY DT
    Continuing Medical Education Questions: June 2023.
    Am J Gastroenterol. 2023;118:935.
    >> Share

    May 2023
  178. MARKOVINOVIC A, Quan J, Herauf M, Hracs L, et al
    Adverse Events & Serological Responses Following SARS-CoV-2 Vaccination in Individuals with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2023 May 22. doi: 10.14309/ajg.0000000000002337.
    >> Share

  179. BARNES EL, Zhang X, Long MD, Herfarth HH, et al
    Rate of Colectomy Increases within Twelve Months of Sequential Therapy for Ulcerative Colitis.
    Am J Gastroenterol. 2023 May 22. doi: 10.14309/ajg.0000000000002331.
    >> Share

  180. PARIAN AM, Obi M, Fleshner P, Schwartz DA, et al
    Management of Perianal Crohn's Disease - AJG.
    Am J Gastroenterol. 2023 May 19. doi: 10.14309/ajg.0000000000002326.
    >> Share

  181. LEY D, Leroyer A, Dupont C, Sarter H, et al
    New therapeutic strategies are associated with a significant decrease in colectomy rate in pediatric ulcerative colitis.
    Am J Gastroenterol. 2023 May 4. doi: 10.14309/ajg.0000000000002316.
    >> Share

  182. GOLDOWSKY A, Billings W, Kickel A, Charabaty A, et al
    @MondayNightIBD and the Expanding Gastroenterology Twitterverse: A Study on Continuing Medical Education on #GITwitter.
    Am J Gastroenterol. 2023;118:855-860.
    >> Share

    April 2023
  183. MORTREUX P, Leroyer A, Dupont C, Ley D, et al
    Natural history of anal ulcerations in pediatric-onset Crohn's disease: long-term follow-up of a population-based study.
    Am J Gastroenterol. 2023 Apr 25. doi: 10.14309/ajg.0000000000002301.
    >> Share

  184. COHEN-MEKELBURG S, Van T, Berinstein JA, Yu X, et al
    Characteristics of Facilities with Early and Rapid Ustekinumab Adoption for Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2023 Apr 25. doi: 10.14309/ajg.0000000000002304.
    >> Share

  185. YANG JY, Lund JL, Funk MJ, Hudgens MG, et al
    Utilization of Treat-to-Target Monitoring Colonoscopy after Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).
    Am J Gastroenterol. 2023 Apr 13. doi: 10.14309/ajg.0000000000002294.
    >> Share

  186. MARCHEGIANI F, Laurent A, de'Angelis N
    Abdominal mass in a patient with autoimmune hepatitis, ulcerative colitis and BRCA family history - not always what you expect.
    Am J Gastroenterol. 2023 Apr 11. doi: 10.14309/ajg.0000000000002284.
    >> Share

    March 2023
  187. AHUJA D, Murad MH, Ma C, Jairath V, et al
    Comparative Speed of Early Symptomatic Remission with Advanced Therapies for Moderate-Severe Ulcerative Colitis: A Systematic Review and Network Meta-Analysis.
    Am J Gastroenterol. 2023 Mar 29. doi: 10.14309/ajg.0000000000002263.
    >> Share

  188. OGINO T, Mizushima T, Fujii M, Sekido Y, et al
    Crohn's disease-associated anorectal cancer has a poor prognosis with high local recurrence: a subanalysis of the Nationwide Japanese Study.
    Am J Gastroenterol. 2023 Mar 28. doi: 10.14309/ajg.0000000000002269.
    >> Share

  189. ZORZI F, Rubin DT, Cleveland NK, Monteleone G, et al
    Ultrasonographic Transmural healing in Crohn's disease.
    Am J Gastroenterol. 2023 Mar 28. doi: 10.14309/ajg.0000000000002265.
    >> Share

  190. FINE LS, Zhu S, Shirazi A, Lee JK, et al
    Increased Risk of Hospitalization, Surgery and Venous Thromboembolism Among Patients with Inflammatory Bowel Disease and Malnutrition in a Large, Community-Based Healthcare System.
    Am J Gastroenterol. 2023 Mar 9. doi: 10.14309/ajg.0000000000002241.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016